Snowflake and Five Below Surge in Premarket Trading on Strong Earnings
Yahoo Finance ·
U.S. equity futures traded mixed early Thursday. In premarket action, Snowflake shares skyrocketed over 23 percent after reporting second-quarter results that surpassed expectations and raising its full-year outlook. Adjusted earnings reached 62 cents per share, beating the 45-cent estimate, while revenue climbed 35 percent year-over-year to $1.55 billion. Five Below gained about 4 percent following strong quarterly figures, an increased full-year sales forecast, and a new $600 million share buyback program. Conversely, Hewlett Packard Enterprise shares slipped nearly 3 percent due to ongoing supply chain concerns, and Broadcom dipped roughly 3 percent as its fourth-quarter revenue guidance missed estimates. Meanwhile, Ultragenyx Pharmaceutical shares plummeted more than 44 percent after its late-stage drug trial for Angelman syndrome failed to meet its primary endpoint.
AI 시장 분석
In the US pre-market, Snowflake and Five Below surged 23% and 4%, respectively, driven by better-than-expected earnings and raised guidance. Conversely, Hewlett Packard Enterprise and Broadcom declined despite solid earnings due to supply constraints and guidance that fell short of expectations. Ultragenyx plummeted 44% following a clinical trial failure, highlighting a clear divergence in stock performance. Investors are reacting immediately to individual corporate fundamentals and earnings guidance.
상승 영향
- Software — Snowflake posted Q2 adjusted EPS of 62 cents and product revenue of $1.49 billion while raising annual guidance, sending the stock surging 23%.
- Consumer Goods — Five Below reported better-than-expected net sales of $126 million, raised its annual guidance, and announced a $600 million share buyback, lifting the stock 4%.
하락 영향
- Semiconductors — Broadcom issued a Q4 revenue outlook of $3.48 billion, missing the estimated $3.505 billion, causing the stock to drop 3%.
- Biotech — Ultragenyx crashed 44% after its new drug apazunense failed to meet the primary endpoint in a Phase 3 clinical trial.
DYAX 전담 분석
Snowflake's Q2 revenue increased 35% year-over-year to $155 million, marking its third consecutive quarter of accelerating growth, while Five Below also led strength with a 14.1% increase in same-store sales. Meanwhile, selling pressure emerged for Broadcom as its Q4 revenue outlook was projected at $3.48 billion, falling short of the market estimate of $3.505 billion.
The bullish scenario is that earnings surprises in the cloud and retail sectors will support overall tech sentiment and drive further gains, while the bearish scenario is that concerns over supply chain constraints and guidance misses will spread to other large-cap tech stocks. Key monitoring indicators are big tech companies' AI chip demand and supply chain stabilization.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 46% · Bearish (Short) 54%
392 participants
Related News
- Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Thursday; Snowflake to Advance, Broadcom to Decline
- Robinhood's Direct Crypto Revenue Proves to Be a Double-Edged Sword
- Dell Shares Surge Following Strong Guidance
- Tesla Hosts Cybercab Unveiling Event in Texas Today
- Broadcom Shares Decline as Q4 Revenue Guidance Misses Wall Street Expectations
- Where Will GE Vernova Stand in a Decade?
